Production (Stage)
Corbus Pharmaceuticals Holdings, Inc.
CRBP
$8.74
-$0.09-1.02%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -48.97% | 9.85% | 18.46% | 24.29% | 33.36% |
| Total Depreciation and Amortization | -15.35% | -8.22% | -11.09% | -15.65% | -18.43% |
| Total Amortization of Deferred Charges | -74.31% | -51.91% | -29.92% | -12.36% | 5.76% |
| Total Other Non-Cash Items | 100.20% | 2.07% | -14.41% | -52.11% | -56.13% |
| Change in Net Operating Assets | -529.71% | -236.18% | -138.72% | -46.64% | -43.05% |
| Cash from Operations | -73.55% | -15.77% | 1.83% | 20.00% | 31.14% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 92.73% | -440.36% | -423.09% | -563.12% | -827.57% |
| Cash from Investing | 92.73% | -440.36% | -423.09% | -563.12% | -828.59% |
| Total Debt Issued | -- | -- | -79.66% | -79.66% | -79.66% |
| Total Debt Repaid | -143.14% | -376.75% | -569.17% | -274.09% | -147.14% |
| Issuance of Common Stock | -39.05% | 84,624.64% | 84,624.64% | 67,261.84% | 293,886.25% |
| Repurchase of Common Stock | 91.56% | 91.56% | 7.50% | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -42.24% | 6,004.91% | 24,258.06% | 485,286.36% | 32,611.42% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -29.24% | 205.93% | 784.04% | 188.03% | 113.64% |